Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Is the selected listing in stock, low stock, pre-order, or out of stock
Although GLP-1RAs can reduce body weight by 15%25% in controlled settings, real-world adherence is limited, and nearly 70% of patients experience weight regain after discontinuation, raising the risk of long-term pharmacological dependence ( Looking ahead, the future of GLP-1based therapy will depend on addressing safety concerns, improving long-term adherence, and expanding clinical indications
Typical response time is about one day
JAMA 306(14):15491556
US$ 28.40
US$ 23.96
US$ 21.29
US$ 24.58
